CD44 and prostate carcinoma: Here, we analyzed the expression patterns of two PCSC-associated membrane markers, CD44 and EpCAM [22, 23], in 3D-cultured prostatospheroids derived from three different prostate cancer cell lines (AR-positive LNCaP and VCaP; AR-negative DU145).